Search
for
Sort by
Research 391–420 of 1000+
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
- Dermoscopic evaluation of intralesional pentoxifylline in the treatment of alopecia areata
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- Expert consensus on systemic treatment activation and grading evaluation for alopecia areata
- Real-world evidence in alopecia areata treatment: A narrative review
- Vitamin D and its Analogs in Treatment of Mild to Moderate Alopecia Areata: Systematic Review and Meta-Analysis.
- The Effectiveness and Safety of Three Treatment Regimens of Topical Minoxidil 5.0%, Betamethasone 0.064% w/w, and Castor and Jojoba Oils for Alopecia Areata: A Multicenter Cohort Study
- Comparative study between intralesional injection of prostaglandin F2α alone or combined with corticosteroids in the treatment of alopecia areata
- Effectiveness of oral tofacitinib treatment on patients with moderate‐to‐severe alopecia areata in Iran
- Trichoscopy pattern and evaluation of serum vitamin D status in alopecia areata
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Sesame and Pumpkin Seed Oil are New Effective Topical Therapies for Alopecia Areata
- Alopecia and Thyroid Disease
- Alopecia and its medical management
- Incidence and prevalence of alopecia areata in the Australian primary care setting: A retrospective analysis of electronic health record data
- Autoimmunity: Alopecia Areata
- Recent Advances in the Pathogenesis of Autoimmune Hair Loss Disease Alopecia Areata
- The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
- Immunoregulatory Effects of Myeloid-Derived Suppressor Cell Exosomes in Mouse Model of Autoimmune Alopecia Areata
- SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- Exploring the overlap between alopecia areata and major depressive disorder: Epidemiological and genetic perspectives
- Health‐related quality of life of adult and adolescent patients living with alopecia areata in Australia
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- Anxiety, depression, and quality of life in children and adults with alopecia areata: A systematic review and meta-analysis
- Patient-reported outcome improvements following scalp hair regrowth among patients with Alopecia Areata: analysis of the ALLEGRO-2b/3 trial
- Predominant expression of interleukin (IL)‐17 in chronic alopecia areata compared to IFN‐γ in pathogenic Th17 cells, tissue‐resident memory T cells and natural killer cells
- Association of resilience and perceived stress in patients with alopecia areata: A cross-sectional study
- Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition